INTERNATIONAL:
1. Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study.Sharma S, Gupta V, Maiti A, Int J Retina Vitreous. 2021 Mar 24;7(1):24.
2. Intraoperative breakage of a reused 25 gauge ILM peelig forceps. Roy Madhurima, Roy Sangeeta, Maiti Aniruddha , International Journal of Retina, v. 4, n.2,p.178,sep.2021
3. Brolucizumab in NeovascularAge-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study Chakraborty D, Maiti A, Sheth JU, Boral S, Mondal S, Nandi K, Sinha T, Das A Clinical Ophthalmology 2021, 15:3787-3795
4. Roy Madhurima , Maiti Aniruddha . INTRAOPERATIVE BREAKAGE OF A REUSED 25 GAUGE ILM PEELING FÓRCEPS. International Journal of Retina, [S.l.], v. 4, n. 2, p. 178, sep. 2021. ISSN 2614-8536.
5. Vitrect omized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.Iglicki M, Maiti A, D’Amico Ricci G, Udaondo P, Loewenstein A, Chhablani J, Zur D.Eye (Lond). 2022 Jan 18. doi: 10.1038/s41433-022-01931-9. Online ahead of print.PMID: 35043004 Dr Aniruddha Maiti
6. Safety of 10000 intravitreal dexamethasone implants.British Journal of Ophthalmology,2020 Jan;104(1):39-46,Bindu Rajesh et al, Aniruddha Maiti
7. India’s Vitreo Retinal Development Project: Providing Advanced Training to Retina Surgeons Retina Times Fall 2017 Issue 71, Volume 35, No. 4 Pravin Dugel,Aniruddha Maiti
8. Rising to the Challenges of Retina Care in India Retina Times Winter 2017 Issue 72,Volume 35, No.5 Pravin Dugel,Aniruddha Maiti, Ratish Chandra Paul, V.Narendran
9. Maitreya Maity,Dev Kumar Das,Dhiraj Manohar,DhaneChandan Chakraborty, Aniruddha Maiti , Journal of Medical and Biological Engineering Fusion of EntropyBased Thresholding and Active Contour Model for Detection of Exudate and Optic Disc in
Color Fundus Images December 2016, Volume 36, Issue 6, pp 795–809
10. DattaA;MaitiA; Uparkar M,Autofluorescence, imaging.Ophthalmology 2008;115(10):1853-4;
11. UparkarM; Maiti A; Natarajan S Correspondence. Retina (Philadelphia, Pa.) 2008;28(3):527
12. Aspergillus-induced Malignant Glaucoma. Jain V, Maiti A, Shome D, Borse N, Natarajan S, Cornea. 2007 Jul ;26 (6):762-763
13. Report on Sunayana 2007: 65th Annual Conference of the All-India Ophthalmological Society Natarajan S, Kothari M, Maiti A,
Ramakrishnan K Expert Review of Ophthalmology June 2007, Vol. 2, No. 3, Pages 341-342
14. An Unusual Ocular Manifestation in Fanconi Anemia: Anterior Ischemic syndrome. JainV,Shome D, Maiti A, Natarajan S, Eye 2007;21:1449-1450
15. Correspondence. Uparkar M, Maiti A, Natarajan S.
Retina. 2008 Mar;28(3):527; author reply 527-8. doi: 10.1097/IAE.0b013e31815f3c74.
PMID: 18327151 No abstract available.
16. Inadvertent intralenticular Ozurdex removal. Roy M, Maiti A, Das S, Das SS.
Oman J Ophthalmol. 2022 Mar 2;15(1):119-120. doi: 10.4103/ojo.ojo_144_21. eCollection 2022 Jan-Apr.
PMID: 35388264 Free PMC article. No abstract available.
17. Aspergillus-induced malignant glaucoma. Jain V, Maiti A, Shome D, Borse N, Natarajan S.
Cornea. 2007 Jul;26(6):762-3. doi: 10.1097/ICO.0b013e31805fc37b.
PMID: 17592335
18. Autofluorescence imaging. Datta A, Maiti A, Uparkar M.
Ophthalmology. 2008 Oct;115(10):1853-4; author reply 1854. doi: 10.1016/j.ophtha.2008.06.028.
PMID: 18929171 No abstract available.
19. Safety of 6000 intravitreal dexamethasone implants.
Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group.
Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30.
PMID: 31040132
20. Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes.
Chakraborty D, Maiti A, Sheth JU, Mondal S, Boral S, Nandi K, Sinha TK, Das A.
Clin Ophthalmol. 2022 Dec 23;16:4303-4313. doi: 10.2147/OPTH.S395577. eCollection 2022.
PMID: 36583092 Free PMC article.
21. Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Iglicki M, Busch C, Lanzetta P, Sarao V, Veritti D, Rassu N, Lupidi M, Cebeci Z, Fraser-Bell S, Bernal-Morales C, Sala-Puigdollers A, Zarranz-Ventura J, Gallego-Pinazo R, Maiti A, D’Amico Ricci G, Udaondo P, Loewenstein A, Chhablani J, Zur D.
Eye (Lond). 2023 Feb;37(2):280-284. doi: 10.1038/s41433-022-01931-9. Epub 2022 Jan 18.
PMID: 35043004 Free PMC article.
22. Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study.
Chakraborty D, Maiti A, Sheth JU, Boral S, Mondal S, Nandi K, Sinha T, Das A.
Clin Ophthalmol. 2021 Sep 7;15:3787-3795. doi: 10.2147/OPTH.S328160. eCollection 2021.
PMID: 34522081 Free PMC article.
23. Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study.
Sharma S, Gupta V, Maiti A, Natesh S, Saxena S, Dave V, Parmar V, Sampangi R, Murthy H, Dharwadkar S, Yadav NK, Joshi S, Mayor R, Ratra D, Basu S, Goel N, Chaturvedi A, Patel R, Jose V.
Int J Retina Vitreous. 2021 Mar 24;7(1):24. doi: 10.1186/s40942-021-00293-w.
PMID: 33762008 Free PMC article.
24. Pooled Multicenter Safety Analysis of Lupin’s Intravitreal Biosimilar Ranibizumab (Ranieyes) in Chorioretinal Vascular Diseases.
Chakraborty D, Sinha TK, Sinha S, Maiti A, Mukherjee A, Nandi K, Das S, Majumdar S, Rungta D, Bhattacharya R.
Ophthalmol Ther. 2024 Nov 19. doi: 10.1007/s40123-024-01065-z. Online ahead of print.
PMID: 39560702
NATIONAL:
1. Unilateral loss of vision following snake bite, Ghosh AK, Bhaduri G, Sarkar AD, Mondal LK, Maiti A, Kishore V, Datta A, Chanda S. J Indian Med Assoc. 2006 Jul ;104 (7):404-5
2. Ophthalmic artery occlusion: A cause of unilateral visual loss following spine surgery. Kothari M, Maiti A, Indian Journal of Ophthalmology,2007;Sept-oct 399-400
3. Transconjunctival Sutureless Vitrectomy S.Natarajan, Ashad Sivaraman, Aniruddha Mahindrakar, Aniruddha Maiti, Mahesh Uparkar, Vandana Jain, Soumen Mondel TNOA,2007 Sept;45(3):9-22
4. Principal components’ analysis of multifocal electroretinogram in retinitis pigmentosa. Aniruddha Maiti, Mahesh Uparkar, Sundaram Natarajan, Nishikanth Borse, Jaydeep Walinjkar ,Indian Journal of Ophthalmology,2011:Sept-Oct,59(5):353-357
5. Early intervention in Acute Retinal Necrosis, Maiti Aniruddha, Bhatt Chirag,Roy Sudip ,Chatterjee PK, Sinha S, Bengal Journal of Ophthalmology, Vol 38, Issue -1,Dec 2011,17-18
6. Multifocal-ERG -Review Article. Aniruddha Maiti, Bengal Journal of Ophthalmology, Vol 39,Issue 1,Dec 2012,1-6
7. To estimate the oxidative stress levels in CSR, Aniruddha Maiti, Surojit Bose,G Mukherjee,Knika Agarwal,Chirag Bhatt,Ratish C Paul, Bengal Journal of Ophthalmology,Vol.40, Isuue 1,Nov 2013,66-67
8. Computer Vision Approach to Diabetic Retinopathy Screening, Aniruddha Maiti,Chandan Chakraborty, Kanika Agarwal, Dr Rahul Bahekar , Dr Chirag Bhatt, Dr R C Paul, Bengal Journal of Ophthalmology,Vol.39, Isuue 1,Nov 2014
9. The Effect of Intravitreal Ranibizumab Injection in Diabetic Macular Edema Arnab Pal, Ashim Kumar Dey, Aniruddha Maiti, Bengal Journal of Ophthalmology,Vol. 46, Issue 1, Jan – June 2019 ,26-30
10. Safety and efficacy of retro-pupillary iris claw intra ocular lens in aphakia with inadequate capsular support – Our experience ,Priyanka Khandelwal, Aniruddha Maiti, Bengal Journal of Dr Aniruddha Maiti Ophthalmology,Volume 45,jan-June 2018,40-48
11. A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India.Sengupta S, Sindal MD, Shanmugam PM, Bhende P, Ratra D, Nagpal M, Narayanan R, Rajendran A, Saravanan V, Kelkar A, Maiti A, Chakraborty D, Dogra M, Behera S.Indian J Ophthalmol. 2021 Nov;69(11):3308-3318.IJO_1265_21
12.Retinal racemose hemangioma and macroaneurysm with multilayered hemorrhage: A case report Sangeeta Roy, Aniruddha Maiti, Indian Journal of Ophthalmology – Case Reports, Year 2021, Volume 1, Issue 4 [p. 739-741] IJO_2496_20
13. Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment – A quasi-randomized retrospective study.Chakraborty D, Maiti A, Kelkar A, Sengupta S, Roy S, Bolisetty M, Kothari A, Majumder J.Indian J Ophthalmol. 2021 Nov;69(11):3283-3287. IJO_1264_21
14. Brolucizumab-associated intraocular inflammation in Indian patients by VRSI study group.
Agarwal M, Muralidhar A, Shanmugam MP, Kothari A, Dudani A, Maiti A, Arora A, Jayadev C, Gupta C, Shroff D, Chakraborty D, Pillai GS, Lahiri K, Verma L, Gopalakrishnan M, Narayanan R, Mishra SK, Patil S, Choudhary S, Chakraborty S, Natesh S, Koundanya V, Aggarwal V.
Indian J Ophthalmol. 2024 Aug 1;72(8):1156-1161. doi: 10.4103/IJO.IJO_2973_23. Epub 2024 Jul 29.
PMID: 39078959 Free PMC article.
15. Preferred practice patterns in aphakia management in adults in India: A survey.
Kelkar AS, Kelkar J, Bhende P, Narayanan R, Maiti A, Bolisetty M, Singhvi P.
Indian J Ophthalmol. 2022 Aug;70(8):2855-2860. doi: 10.4103/ijo.IJO_319_22.
PMID: 35918929 Free PMC article.
16. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes – 1-year outcomes from a quazi-randomized study in India.
Chakraborty D, Mondal S, Sengupta S, Maiti A, Boral S, Das A, Sinha TK, Nandi K.
Indian J Ophthalmol. 2024 Jul 1;72(7):1001-1006. doi: 10.4103/IJO.IJO_1447_23. Epub 2024 Apr 16.
PMID: 38622856 Free PMC article. Clinical Trial.
17. Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study.
Chakraborty D, Maiti A, Sengupta S, Mondal S, Nandi K, Chakraborty S.
Indian J Ophthalmol. 2022 Apr;70(4):1295-1299. doi: 10.4103/ijo.IJO_2513_21.
PMID: 35326038 Free PMC article.
18. A Delphi method based consensus statement for surgical management of proliferative diabetic retinopathy in India.
Sengupta S, Sindal MD, Shanmugam PM, Bhende P, Ratra D, Nagpal M, Narayanan R, Rajendran A, Saravanan V, Kelkar A, Maiti A, Chakraborty D, Dogra M, Behera S.
Indian J Ophthalmol. 2021 Nov;69(11):3308-3318. doi: 10.4103/ijo.IJO_1265_21.
PMID: 34708794 Free PMC article.
19. Incidence, clinical features, risk factors, and outcomes of Intraocular inflammation following Brolucizumab in Indian eyes – A multicentric study.
Chakraborty D, Mondal S, Sengupta S, Abbas Z, Chandra K, Boral S, Maiti A, Roy S, Mukherjee A, Das A, Chakraborty S, Nag P.
Indian J Ophthalmol. 2023 May;71(5):1979-1985. doi: 10.4103/IJO.IJO_2688_22.
PMID: 37203069 Free PMC article.
20. Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment – A quasi-randomized retrospective study.
Chakraborty D, Maiti A, Kelkar A, Sengupta S, Roy S, Bolisetty M, Kothari A, Majumder J.
Indian J Ophthalmol. 2021 Nov;69(11):3283-3287. doi: 10.4103/ijo.IJO_1264_21.
PMID: 34708788 Free PMC article. Clinical Trial.
21. Ophthalmic artery occlusion: a cause of unilateral visual loss following spine surgery.
Kothari MT, Maiti A.
Indian J Ophthalmol. 2007 Sep-Oct;55(5):401-2. doi: 10.4103/0301-4738.33841.
PMID: 17699964 Free PMC article. No abstract available.
22. Principal components’ analysis of multifocal electroretinogram in retinitis pigmentosa.
Maiti A, Uparkar M, Natarajan S, Borse N, Walinjkar J.
Indian J Ophthalmol. 2011 Sep-Oct;59(5):353-7. doi: 10.4103/0301-4738.83610.
PMID: 21836339 Free PMC article.
23. Unilateral loss of vision following snakebite.
Ghosh AK, Bhaduri G, Sarkar AD, Mondal LK, Maiti A, Kishore V, Datta A, Chanda S.
J Indian Med Assoc. 2006 Jul;104(7):404-5.
PMID: 17240816
Digital publication :
1. 3D viewing system in Ophthalmology -June,2021 (EOPHTHA Website)
no images were found